Skip to content
We’ve expanded our free plan so you can explore more of Valuesider. Check out the updated pricing page to see what’s now available for free!
User

Glenn Greenberg recent buys & sells (2015 Q4)

Brave Warrior Advisors

Brave Warrior Advisors Portfolio Changes

Purchase & sale details

Portfolio value:
$2.52B (-$627M)
Previous value:
$3.15B
# of changes:
12
New positions:
0
Reported for:
31 Dec 2015 (Q4)
Latest filing date:
16 Feb 2016
Brave Warrior Advisors has disclosed a total of 12 changes to the portfolio in the (2015 Q4) SEC report(s): increased the number of shares of 4, decreased the number of shares of 7 and completely sold out 1 position(s).

What stocks did Glenn Greenberg buy in 2015 Q4?

During 2015 Q4 Glenn Greenberg has purchased 4 securities: (VRX) Valeant Pharmaceuticals International Inc (added shares +12.09%), (SCHW) Charles Schwab Corp (added shares +5.23%), (BN) Brookfield Corp (added shares +4.91%) and (JPMWS) JPMORGAN CHASE & CO-CW18 (added shares +0.16%).

What did Glenn Greenberg invest in during 2015 Q4?

Glenn Greenberg's top 5 holdings (by % of portfolio) were (VRX) Valeant Pharmaceuticals International Inc (25.22%), (CMPR) CIMPRESS NV (12.58%), (SCHW) Charles Schwab Corp (12.55%), (JPM) JPMorgan Chase & Co (12.51%) and (BN) Brookfield Corp (11.19%).
In the 2015 Q4 report(s) the following changes have been made to the top investments: (VRX) Valeant Pharmaceuticals International Inc (added shares +12.09%), (CMPR) CIMPRESS NV (reduced shares -3.76%), (SCHW) Charles Schwab Corp (added shares +5.23%), (JPM) JPMorgan Chase & Co (reduced shares -0.86%) and (BN) Brookfield Corp (added shares +4.91%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".